Back to CRL
Swiss Life Asset Management Ltd → CRL
Swiss Life Asset Management Ltd CRL Position History
Charles River Laboratories International, Inc. • Healthcare
Quarters held
22
Latest value
$2.9M
Q3 2026
Peak value
$4.6M
First seen
Q2 2021
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2021 | $3.6M |
| Q3 2021 | $312K |
| Q3 2021 | $4.6M |
| Q4 2021 | $3.3M |
| Q1 2022 | $2.3M |
| Q2 2022 | $1.3M |
| Q3 2022 | $1.2M |
| Q4 2022 | $1M |
| Q1 2023 | $2.1M |
| Q2 2023 | $2.2M |
| Q4 2023 | $507K |
| Q1 2024 | $439K |
| Q2 2024 | $251K |
| Q3 2024 | $209K |
| Q4 2024 | $613K |
| Q1 2025 | $319K |
| Q2 2025 | $393K |
| Q3 2025 | $346K |
| Q4 2025 | $467K |
| Q1 2026 | $551K |
| Q2 2026 | $793K |
| Q3 2026 | $2.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.9M | 9.7K | — | — |
| Q2 2026 | $793K | 3.5K | — | — |
| Q1 2026 | $551K | 3.2K | — | — |
| Q4 2025 | $467K | 2.3K | — | — |
| Q3 2025 | $346K | 2.2K | — | — |
| Q2 2025 | $393K | 2.6K | — | — |
| Q1 2025 | $319K | 2.1K | — | — |
| Q4 2024 | $613K | 3.3K | — | — |
| Q3 2024 | $209K | 1.1K | — | — |
| Q2 2024 | $251K | 1.2K | — | — |
| Q1 2024 | $439K | 1.6K | — | — |
| Q4 2023 | $507K | 2.1K | — | — |
| Q2 2023 | $2.2M | 10.4K | — | — |
| Q1 2023 | $2.1M | 10.4K | — | — |
| Q4 2022 | $1M | 4.6K | — | — |
| Q3 2022 | $1.2M | 6.0K | — | — |
| Q2 2022 | $1.3M | 6.0K | — | — |
| Q1 2022 | $2.3M | 8.2K | — | — |
| Q4 2021 | $3.3M | 8.7K | — | — |
| Q3 2021 | $4.6M | 11.2K | — | — |
| Q3 2021 | $312K | 757 | — | — |
| Q2 2021 | $3.6M | 9.8K | — | — |
Other funds holding CRL
$508.3M
$422.8M
$422.8M
$371.4M
$362.1M
$334.6M
$328.4M
$323.2M